Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2014 Jul 7;22(5):453–459. doi: 10.1037/a0037396

Figure 3.

Figure 3

Earned infusions at each nicotine dose during acquisition (Phase 1) and reduction (Phase 3).

Earned infusions over the last three sessions of acquisition (Phase 1, filled circles) and reduction (Phase 3, filled squares).Significant increase in infusions earned for from Phase 1 to Phase 3 (p<0.0125), and significant nicotine × phase interaction (p<0.017) denoted by *. Bars represent standard errors